Clinical trial
Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization.
NCT00421252 · Beth Israel Deaconess Medical Center, Other · Terminated
Key facts
| NCT number | NCT00421252 |
|---|---|
| Title | Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization. |
| Official title | Impact of Pre-treatment With 600mg of Clopidogrel (Plavix) on the Incidence of Ischemic and Hemorrhagic Complications in Patients Undergoing Elective Percutaneous Coronary Revascularization.--Prospective Randomized Trial. |
| Lead sponsor | Beth Israel Deaconess Medical Center, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease, Myocardial Ischemia, Bleeding |
| Intervention type | Device, Drug |
| Interventions | clopidogrel 600 mg, arterial access sheath |
| Enrollment | 18 |
| Start date | Jan 1, 2007 |
| Primary completion | Nov 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Jan 11, 2007 |
| Last update posted | Apr 14, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: